HIV- 1 lentivirus tethering to the genome is associated with transcription factor binding sites found in genes that favour virus survival

[1]  J. Kleinjans,et al.  Comparing in vitro human liver models to in vivo human liver using RNA-Seq , 2020, Archives of Toxicology.

[2]  Y. Zhang,et al.  PBX1 is a valuable prognostic biomarker for patients with breast cancer , 2020, Experimental and therapeutic medicine.

[3]  M. Gottikh,et al.  NHEJ pathway is involved in post-integrational DNA repair due to Ku70 binding to HIV-1 integrase , 2019, Retrovirology.

[4]  D. Hay,et al.  Serum Free Production of Three-dimensional Human Hepatospheres from Pluripotent Stem Cells. , 2019, Journal of visualized experiments : JoVE.

[5]  P. Dubus,et al.  Generation of induced pluripotent stem cells-derived hepatocyte-like cells for ex vivo gene therapy of primary hyperoxaluria type 1. , 2019, Stem cell research.

[6]  E. Papapetrou,et al.  Modeling blood diseases with human induced pluripotent stem cells , 2019, Disease Models & Mechanisms.

[7]  Michael Xavier Doss,et al.  Current Challenges of iPSC-Based Disease Modeling and Therapeutic Implications , 2019, Cells.

[8]  A. Ebert,et al.  Studying Human Neurological Disorders Using Induced Pluripotent Stem Cells: From 2D Monolayer to 3D Organoid and Blood Brain Barrier Models. , 2019, Comprehensive Physiology.

[9]  H. Rashidi,et al.  Three-dimensional cell culture: from evolution to revolution , 2018, Philosophical Transactions of the Royal Society B: Biological Sciences.

[10]  Kevin T. Green,et al.  Autologous and Heterologous Cell Therapy for Hemophilia B toward Functional Restoration of Factor IX , 2018, Cell reports.

[11]  Junwen Wang,et al.  NFATc2 enhances tumor-initiating phenotypes through the NFATc2/SOX2/ALDH axis in lung adenocarcinoma , 2017, bioRxiv.

[12]  K. Zeilinger,et al.  Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro , 2016, Archives of Toxicology.

[13]  A. Doherty,et al.  Viral Vectors: The Road to Reducing Genotoxicity. , 2017, Toxicological sciences : an official journal of the Society of Toxicology.

[14]  K. Zeilinger,et al.  Self-assembled 3D spheroids and hollow-fibre bioreactors improve MSC-derived hepatocyte-like cell maturation in vitro , 2016, Archives of Toxicology.

[15]  M. Schneider,et al.  Lentivirus-meditated frataxin gene delivery reverses genome instability in Friedreich ataxia patient and mouse model fibroblasts , 2016, Gene Therapy.

[16]  Hau-San Wong,et al.  A Comparison Study for DNA Motif Modeling on Protein Binding Microarray , 2016, IEEE/ACM Transactions on Computational Biology and Bioinformatics.

[17]  M. Schindler,et al.  Virion encapsidated HIV-1 Vpr induces NFAT to prime non-activated T cells for productive infection , 2016, Open Biology.

[18]  Yu Wang,et al.  Recombinant Laminins Drive the Differentiation and Self-Organization of hESC-Derived Hepatocytes , 2015, Stem cell reports.

[19]  Narasimhan J. Venkatachari,et al.  Temporal transcriptional response to latency reversing agents identifies specific factors regulating HIV-1 viral transcriptional switch , 2015, Retrovirology.

[20]  T. Cheng,et al.  A Facile Method to Establish Human Induced Pluripotent Stem Cells From Adult Blood Cells Under Feeder‐Free and Xeno‐Free Culture Conditions: A Clinically Compliant Approach , 2015, Stem cells translational medicine.

[21]  Feng Liu,et al.  An integrative analysis of TFBS-clustered regions reveals new transcriptional regulation models on the accessible chromatin landscape , 2015, Scientific Reports.

[22]  Li Ma,et al.  ZEB1: At the crossroads of epithelial-mesenchymal transition, metastasis and therapy resistance , 2015, Cell cycle.

[23]  J. Azizkhan-Clifford,et al.  Sp1 and the ‘hallmarks of cancer’ , 2015, The FEBS journal.

[24]  D. Mackey,et al.  iPS Cells for Modelling and Treatment of Retinal Diseases , 2014, Journal of clinical medicine.

[25]  Rudong Li,et al.  A Computational Study Identifies HIV Progression-Related Genes Using mRMR and Shortest Path Tracing , 2013, PloS one.

[26]  Alaine T. Ruthe,et al.  The fetal mouse is a sensitive genotoxicity model that exposes lentiviral-associated mutagenesis resulting in liver oncogenesis. , 2013, Molecular therapy : the journal of the American Society of Gene Therapy.

[27]  C. von Kalle,et al.  Lentiviral vector-based insertional mutagenesis identifies genes associated with liver cancer , 2013, Nature Methods.

[28]  B. Berkhout,et al.  An AP-1 Binding Site in the Enhancer/Core Element of the HIV-1 Promoter Controls the Ability of HIV-1 To Establish Latent Infection , 2012, Journal of Virology.

[29]  Z. Weng,et al.  Functional analysis of transcription factor binding sites in human promoters , 2012, Genome Biology.

[30]  David J. Arenillas,et al.  oPOSSUM-3: Advanced Analysis of Regulatory Motif Over-Representation Across Genes or ChIP-Seq Datasets , 2012, G3: Genes | Genomes | Genetics.

[31]  T. Arnould,et al.  Unbiased proteomic analysis of proteins interacting with the HIV-1 5′LTR sequence: role of the transcription factor Meis , 2012, Nucleic acids research.

[32]  Saw-See Hong,et al.  Quantification of HIV-based lentiviral vectors: influence of several cell type parameters on vector infectivity , 2012, Archives of Virology.

[33]  Chuanfeng Wu,et al.  Stem cell gene therapy: the risks of insertional mutagenesis and approaches to minimize genotoxicity , 2011, Frontiers of medicine.

[34]  A. Schambach,et al.  Rescue of ATP7B function in hepatocyte-like cells from Wilson's disease induced pluripotent stem cells using gene therapy or the chaperone drug curcumin. , 2011, Human molecular genetics.

[35]  F. Bushman,et al.  Distribution of lentiviral vector integration sites in mice following therapeutic gene transfer to treat β-thalassemia. , 2011, Molecular therapy : the journal of the American Society of Gene Therapy.

[36]  E. Kandel,et al.  Long-Distance Effects of Insertional Mutagenesis , 2011, PloS one.

[37]  Alessandro Guffanti,et al.  High-definition mapping of retroviral integration sites identifies active regulatory elements in human multipotent hematopoietic progenitors. , 2010, Blood.

[38]  C. von Kalle,et al.  Lentivirus-mediated reprogramming of somatic cells in the absence of transgenic transcription factors. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[39]  Y. Takeuchi,et al.  Effect of the Internal Promoter on Insertional Gene Activation by Lentiviral Vectors with an Intact HIV Long Terminal Repeat , 2010, Journal of Virology.

[40]  David J. Arenillas,et al.  JASPAR 2010: the greatly expanded open-access database of transcription factor binding profiles , 2009, Nucleic Acids Res..

[41]  A. Schambach,et al.  Insertional transformation of hematopoietic cells by self-inactivating lentiviral and gammaretroviral vectors. , 2009, Molecular therapy : the journal of the American Society of Gene Therapy.

[42]  Aidong Han,et al.  Structural basis of HIV-1 activation by NF-kappaB--a higher-order complex of p50:RelA bound to the HIV-1 LTR. , 2009, Journal of molecular biology.

[43]  Davide Cittaro,et al.  Transcription Factor Binding Sites Are Genetic Determinants of Retroviral Integration in the Human Genome , 2009, PloS one.

[44]  I. Robinson,et al.  Insertional Gene Activation by Lentiviral and Gammaretroviral Vectors , 2008, Journal of Virology.

[45]  Christine Kinnon,et al.  Insertional mutagenesis combined with acquired somatic mutations causes leukemogenesis following gene therapy of SCID-X1 patients. , 2008, The Journal of clinical investigation.

[46]  F. Bushman,et al.  Insertional oncogenesis in 4 patients after retrovirus-mediated gene therapy of SCID-X1. , 2008, The Journal of clinical investigation.

[47]  J. Gray,et al.  Globin lentiviral vector insertions can perturb the expression of endogenous genes in beta-thalassemic hematopoietic cells. , 2008, Molecular therapy : the journal of the American Society of Gene Therapy.

[48]  Shulan Tian,et al.  Induced Pluripotent Stem Cell Lines Derived from Human Somatic Cells , 2007, Science.

[49]  D. Langley,et al.  Changes to the HIV Long Terminal Repeat and to HIV Integrase Differentially Impact HIV Integrase Assembly, Activity, and the Binding of Strand Transfer Inhibitors* , 2007, Journal of Biological Chemistry.

[50]  Shannan J. Ho Sui,et al.  oPOSSUM: integrated tools for analysis of regulatory motif over-representation , 2007, Nucleic Acids Res..

[51]  S. Yamanaka,et al.  Induction of Pluripotent Stem Cells from Mouse Embryonic and Adult Fibroblast Cultures by Defined Factors , 2006, Cell.

[52]  Paul Shinn,et al.  HIV integration site selection: targeting in macrophages and the effects of different routes of viral entry. , 2006, Molecular therapy : the journal of the American Society of Gene Therapy.

[53]  Paul Shinn,et al.  Retroviral DNA Integration: Viral and Cellular Determinants of Target-Site Selection , 2006, PLoS pathogens.

[54]  B. Fehse,et al.  Mutagenesis and oncogenesis by chromosomal insertion of gene transfer vectors. , 2006, Human gene therapy.

[55]  A. Engelman,et al.  Biochemical and genetic analyses of integrase-interacting proteins lens epithelium-derived growth factor (LEDGF)/p75 and hepatoma-derived growth factor related protein 2 (HRP2) in preintegration complex function and HIV-1 replication. , 2006, Virology.

[56]  Paul Shinn,et al.  A role for LEDGF/p75 in targeting HIV DNA integration , 2005, Nature Medicine.

[57]  Sridhar Hannenhalli,et al.  Genome-wide analysis of retroviral DNA integration , 2005, Nature Reviews Microbiology.

[58]  Christof von Kalle,et al.  Oncogenesis following delivery of a nonprimate lentiviral gene therapy vector to fetal and neonatal mice. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[59]  Paul Shinn,et al.  Integration Targeting by Avian Sarcoma-Leukosis Virus and Human Immunodeficiency Virus in the Chicken Genome , 2005, Journal of Virology.

[60]  David J. Arenillas,et al.  oPOSSUM: identification of over-represented transcription factor binding sites in co-expressed genes , 2005, Nucleic acids research.

[61]  F. Bushman,et al.  Retroviral DNA Integration: ASLV, HIV, and MLV Show Distinct Target Site Preferences , 2004, PLoS biology.

[62]  William R. Pearson,et al.  Statistical Significance in Biological Sequence Comparison , 2004 .

[63]  M. Brittan,et al.  Permanent phenotypic correction of hemophilia B in immunocompetent mice by prenatal gene therapy. , 2004, Blood.

[64]  E. Wagner,et al.  AP-1: a double-edged sword in tumorigenesis , 2003, Nature Reviews Cancer.

[65]  F. Bushman.  Targeting Survival Integration Site Selection by Retroviruses and LTR-Retrotransposons , 2003, Cell.

[66]  B. Aronow,et al.  Clonality analysis after retroviral-mediated gene transfer to CD34+ cells from the cord blood of ADA-deficient SCID neonates , 2003, Nature Medicine.

[67]  J. Caldwell,et al.  Identification of Homeodomain Proteins, PBX1 and PREP1, Involved in the Transcription of Murine Leukemia Virus , 2003, Molecular and Cellular Biology.

[68]  Zeger Debyser,et al.  HIV-1 Integrase Forms Stable Tetramers and Associates with LEDGF/p75 Protein in Human Cells* , 2003, The Journal of Biological Chemistry.

[69]  C. von Kalle,et al.  Polyclonal long-term repopulating stem cell clones in a primate model. , 2002, Blood.

[70]  Paul Shinn,et al.  HIV-1 Integration in the Human Genome Favors Active Genes and Local Hotspots , 2002, Cell.

[71]  L. Mulder,et al.  Interaction of HIV-1 Integrase with DNA Repair Protein hRad18* , 2002, The Journal of Biological Chemistry.

[72]  C. von Kalle,et al.  Detection and direct genomic sequencing of multiple rare unknown flanking DNA in highly complex samples. , 2001, Human gene therapy.

[73]  D. Trono,et al.  Self-Inactivating Lentivirus Vector for Safe and Efficient In Vivo Gene Delivery , 1998, Journal of Virology.

[74]  D. Aunis,et al.  Interactions of the transcription factor AP-1 with the long terminal repeat of different human immunodeficiency virus type 1 strains in Jurkat, glial, and neuronal cells , 1995, Journal of virology.

[75]  E. Reddy,et al.  Myb protein binds to human immunodeficiency virus 1 long terminal repeat (LTR) sequences and transactivates LTR-mediated transcription. , 1990, Proceedings of the National Academy of Sciences of the United States of America.

[76]  A. Fauci,et al.  Tumor necrosis factor alpha activates human immunodeficiency virus type 1 through induction of nuclear factor binding to the NF-kappa B sites in the long terminal repeat. , 1989, Proceedings of the National Academy of Sciences of the United States of America.

[77]  D Harrich,et al.  Role of SP1-binding domains in in vivo transcriptional regulation of the human immunodeficiency virus type 1 long terminal repeat , 1989, Journal of virology.

[78]  S. Goff,et al.  Host proteins interacting with the Moloney murine leukemia virus integrase : Multiple transcriptional regulators and chromatin binding factors , 2008 .

[79]  E. Serfling,et al.  NFAT transcription factors control HIV-1 expression through a binding site downstream of TAR region. , 2003, Immunobiology.

[80]  H. Varmus,et al.  The Interactions of Retroviruses and their Hosts , 1997 .